Forum Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-28,571
Closed -$1.45M 764
2025
Q4
$1.45M Sell
28,571
-23
-0.1% -$1.18K 0.02% 178
2025
Q3
$1.59M Buy
28,594
+4,567
+19% +$267K 0.02% 161
2025
Q2
$1.66M Buy
24,027
+286
+1% +$19.5K 0.03% 146
2025
Q1
$1.65M Sell
23,741
-156
-0.7% -$12.9K 0.03% 138
2024
Q4
$2.06M Buy
23,897
+219
+0.9% +$23.7K 0.03% 118
2024
Q3
$2.82M Buy
23,678
+257
+1% +$34.3K 0.05% 72
2024
Q2
$3.34M Buy
23,421
+597
+3% +$79.1K 0.06% 63
2024
Q1
$2.93M Sell
22,824
-568
-2% -$67.6K 0.05% 81
2023
Q4
$2.42M Sell
23,392
-1,492
-6% -$148K 0.05% 77
2023
Q3
$2.26M Buy
24,884
+370
+2% +$32.6K 0.05% 75
2023
Q2
$1.98M Buy
24,514
+1,888
+8% +$154K 0.04% 85
2023
Q1
$1.8M Buy
22,626
+10
+0% +$709 0.05% 87
2022
Q4
$1.53M Buy
22,616
+2
+0% +$117 0.05% 90
2022
Q3
$1.13M Buy
22,614
+124
+0.6% +$6.64K 0.05% 100
2022
Q2
$1.25M Hold
22,490
0.06% 102
2022
Q1
$1.25M Buy
22,490
+12
+0.1% +$616 0.06% 99
2021
Q4
$1.26M Buy
+22,478
New +$1.22M 0.06% 97

Other funds holding NVO

Forum Financial Management's NVO Position: Q1 2026 in Review

Forum Financial Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 28,571 shares — an estimated $1.45M sold.

Forum Financial Management first reported a position in NVO in Q4 2021 and held it in 17 quarters. The position peaked at $3.34M in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Forum Financial Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Forum Financial Management sold 28,571 Novo Nordisk shares in Q1 2026, an estimated $1.45M.
  • Forum Financial Management first reported a position in Novo Nordisk in Q4 2021 and held it in 17 quarters.
  • Forum Financial Management's Novo Nordisk position peaked at $3.34M in Q2 2024.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Forum Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.